Home / Drug shortages / Lorazepam Injection

Lorazepam Injection — FDA Drug Shortage

Current — Hikma Pharmaceuticals USA, Inc.

The FDA lists a drug shortage record for Lorazepam Injection (injection) from Hikma Pharmaceuticals USA, Inc. with status Current. The shortage was first posted on 09/05/2018. Reported reason: Demand increase for the drug

Shortage Details

Status
Current
Company
Hikma Pharmaceuticals USA, Inc.
Package NDC
0641-6001-25
Dosage Form
Injection
Presentation
Ativan, Injection, 2 mg/1 mL (NDC 0641-6001-25)
Initial Posting
09/05/2018
Revised Date

Reason

Demand increase for the drug

FDA data resources